Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/7/26 16:05 | 1/5/26 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | 2 | S.d | -1,151 | 9.41 | 0 | -122 | 1,106 | D | |||||||||||||||
1/7/26 16:05 | 1/5/26 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Schultes Birgit C | MA | O | EVP,Chie | 1 | S | -78 | 9.21 | 0 | -9 | 99 | D | |||||||||||||||
1/7/26 16:05 | 1/5/26 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Basta James | MA | O | EVP,GC | 1 | S | -96 | 9.21 | 0 | -10 | 102 | D | |||||||||||||||
1/7/26 16:04 | 1/5/26 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | 1 | S | -110 | 9.21 | 0 | -12 | 121 | D | |||||||||||||||
1/7/26 16:03 | 1/5/26 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Clark Eliana | MA | O | EVP,Chie | 1 | S | -88 | 9.21 | 0 | -10 | 87 | D | |||||||||||||||
1/7/26 16:02 | 1/5/26 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Dulac Edward J III | MA | O | EVP,CFO | 1 | S | -59 | 9.21 | 0 | -6 | 100 | D | |||||||||||||||
1/7/26 16:01 | 1/5/26 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Dube Michael P | MA | O | VP,Chief | 1 | S | -28 | 9.21 | 0 | -3 | 52 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |